title: Metastatic prostate cancer presenting as paraneoplastic pemphigus: a favourable clinical response to combined androgen blockade and conventional immunosuppressive therapy.
authors.forename: M D
authors.initials: MD
authors.lastname: Mignogna
authors.forename: G
authors.initials: G
authors.lastname: Fortuna
authors.forename: S
authors.initials: S
authors.lastname: Leuci
authors.forename: D
authors.initials: D
authors.lastname: Adamo
authors.forename: E
authors.initials: E
authors.lastname: Ruoppo
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D010257:Paraneoplastic Syndromes / Q000188:drug therapy* / Q000473:pathology; D010392:Pemphigus / Q000188:drug therapy* / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D007166:Immunosuppressive Agents